N-Myc increases the stability of AURKA by blocking its association with the E3 ubiquitin ligase FBXW7 and binds to the promoters of target genes such as NSE, Syn, and AR to control their expression, ultimately resulting in NEPC tumor progression [159]. This evidence concerns the gene AR and neoplasm.